tissue inhibitor of metalloproteinases 3
Showing 1 - 25 of >10,000
Abdominal Aortic Aneurysm Trial in Hull (Atorvastatin, Placebo)
Completed
- Abdominal Aortic Aneurysm
- Atorvastatin
- Placebo
-
Hull, United KingdomHull & east Yorkshire Hospitals NHS Trust
Feb 22, 2021
MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Atlanta, Columbus (drug, biological,
Completed
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +8 more
- PI3K inhibitor BKM120
- +3 more
-
Atlanta, Georgia
- +1 more
Jun 27, 2022
Influence of Specifically Designed Exercise Program on Serum Matrix Metalloproteinases and Functional Status in Women With
Completed
- Influence of Specifically Designed Exercise Program on Serum Matrix Metalloproteinases and Functional Status in Women With Postmenopausal Osteoporosis
- exercises
-
Belgrade, SerbiaTamara Filipovic
Nov 14, 2022
Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma Trial in Seattle
Recruiting
- Metastatic Leiomyosarcoma
- +17 more
- Itacitinib
- Laboratory Biomarker Analysis
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 13, 2022
MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma Trial in Columbus (drug, biological,
Active, not recruiting
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +9 more
- BTK inhibitor PCI-32765
- +5 more
-
Columbus, OhioOhio State University Medical Center
Jun 27, 2022
Periodontal Diseases, Periodontal Attachment Loss, Periodontal Disease, AVDC Stage 3 Trial in Istanbul (low level laser therapy,
Completed
- Periodontal Diseases
- +4 more
- low level laser therapy
- non-surgical periodontal treatment
-
Istanbul, TurkeyBeykent University
Jan 31, 2022
Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma Trial in Providence (Gemcitabine, 9-ING-41,
Withdrawn
- Soft Tissue Sarcoma
- +12 more
- Gemcitabine
- +2 more
-
Providence, Rhode Island
- +1 more
Nov 30, 2021
Heart Transplantation Trial in Duesseldorf (Remote ischemic preconditioning)
Recruiting
- Heart Transplantation
- Remote ischemic preconditioning
-
Duesseldorf, NRW, GermanyUniversity Hospital Duesseldorf
Jun 20, 2022
Resectable Soft Tissue Sarcoma, Soft Tissue Sarcoma Trial in United States (Navtemadlin, Radiation Therapy)
Recruiting
- Resectable Soft Tissue Sarcoma
- Soft Tissue Sarcoma
- Navtemadlin
- Radiation Therapy
-
Goodyear, Arizona
- +52 more
Jul 21, 2022
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +20 more
- panobinostat
- +6 more
-
Scottsdale, Arizona
- +1 more
May 6, 2022
Gingivitis Trial in Wuerzburg (Pycnogenol, Placebo)
Recruiting
- Gingivitis
- Pycnogenol
- Placebo
-
Wuerzburg, GermanyDept. of Periodontology, Center for Oral Health
Mar 27, 2023
Out-Of-Hospital Cardiac Arrest (OHCA) Trial (Individualized blood pressure strategy)
Not yet recruiting
- Out-Of-Hospital Cardiac Arrest (OHCA)
- Individualized blood pressure strategy
- (no location specified)
Dec 23, 2022
Critically Ill, Acute Kidney Injury, Sepsis Trial in Münster (Remote ischemic preconditioning (RIPC), Sham RIPC)
Not yet recruiting
- Critically Ill
- +2 more
- Remote ischemic preconditioning (RIPC)
- Sham RIPC
-
Münster, GermanyUniversity Hospital Münster; Department of Anesthesiology, Inten
Apr 13, 2023
Urinary Molecular Signature Complements Clinical Data to Predict
Recruiting
- Acute Kidney Injury
- pathogenesis of perioperative acute kidney injury
- urine collection
-
Gainesville, FloridaUF Health
Oct 20, 2022
Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Extranodal Marginal Zone Lymphoma of
Active, not recruiting
- Recurrent B-Cell Non-Hodgkin Lymphoma
- +22 more
- Ibrutinib
- +3 more
-
Scottsdale, Arizona
- +1 more
Aug 10, 2021
Tuberculosis Trial in Singapore (Doxycycline, Placebo)
Not yet recruiting
- Tuberculosis
- Doxycycline
- Placebo
-
Singapore, SingaporeNational University Hospital
Jul 21, 2022
Multiple Sclerosis Trial in Shreveport (Interferon beta 1a, oral doxycycline)
Completed
- Multiple Sclerosis
- Interferon beta 1a, oral doxycycline
-
Shreveport, LouisianaLSU Health Sciences Center Shreveport
Oct 11, 2022
Spina Bifida Trial in Rennes cedex 9 (Collection of a urine sample, Magnetic Resonance Imaging of the bladder)
Not yet recruiting
- Spina Bifida
- Collection of a urine sample
- Magnetic Resonance Imaging of the bladder
-
Rennes cedex 9, CHU De Rennes, FranceRennes University Hospital
Sep 14, 2023
Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma Trial (fruquintinib, Envafolimab)
Not yet recruiting
- Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma
- (no location specified)
Jul 10, 2023
Pulmonary Infection, COVID-19, Extracellular Matrix Alteration Trial in Surabaya (MMP-9 and TIMP-1)
Completed
- Pulmonary Infection
- +2 more
- MMP-9 and TIMP-1
-
Surabaya, East Java, IndonesiaUniversitas Airlangga Hospital
May 2, 2023
Cell Cycle Arrest Proteins for Early Diagnosis of Acute Kidney
Recruiting
- Acute Kidney Injury
- Nephrocheck (AKI score)
-
Milan, ItalyFondazione IRCCS Ca'Granda - Ospedale Maggiore Policlinico
Jun 19, 2023
High-Risk Localized Soft Tissue Sarcoma Trial in Shanghai (Surufatinib, Sintilimab, Radiotherapy)
Recruiting
- High-Risk Localized Soft Tissue Sarcoma
- Surufatinib
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Apr 20, 2023
Non-Hodgkin's Lymphoma, Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Ann Arbor
Recruiting
- Non-Hodgkin's Lymphoma
- +18 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Mar 11, 2021